Type:Notice
Citation:90 FR 13732
Reading Time:less than a minute
PCI Pharma Services submitted a proposal to the Foreign-Trade Zones (FTZ) Board on November 21, 2024, to begin production activities at their facilities in Croydon and Philadelphia, Pennsylvania, within FTZ Subzone 35L. This notification adhered to the FTZ Board's regulations, and the public had the opportunity to comment on it as announced in the Federal Register on November 29, 2024. On March 21, 2025, the FTZ Board decided that no further review was needed, authorizing the proposed production activities in accordance with FTZ regulations.
Simple Explanation
PCI Pharma Services wants to make medicines in two places in Pennsylvania, and a special group that helps with trade said it's okay for them to start doing this.